{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:34:01Z","timestamp":1748320441315,"version":"3.40.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2020-2-7131","2020-2-7131","2020-2-7131","2020-2-7131","2020-2-7131","2020-2-7131"],"award-info":[{"award-number":["2020-2-7131","2020-2-7131","2020-2-7131","2020-2-7131","2020-2-7131","2020-2-7131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"DOI":"10.1186\/s12937-025-01128-2","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T13:39:47Z","timestamp":1745674787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of structured exercise and oat supplementation for treating non-alcoholic fatty liver disease: protocol of a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiahui","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"1","key":"1128_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology (Baltimore MD). 2018;67(1):123\u201333. https:\/\/doi.org\/10.1002\/hep.29466.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"6","key":"1128_CR2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/hep.26986","volume":"59","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology (Baltimore. Md). 2014;59(6):2188\u201395. https:\/\/doi.org\/10.1002\/hep.26986.","journal-title":"Md)"},{"key":"1128_CR3","doi-asserted-by":"publisher","unstructured":"Eslam M, Sanyal AJ, George J. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158 (7):1999\u20132014.e1991. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"1128_CR4","doi-asserted-by":"publisher","unstructured":"Duell PB, Welty FK, Miller M, Chait A, Hammond G, Ahmad Z, Cohen DE, Horton JD, Pressman GS, Toth PP. (2022) Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, thrombosis, and vascular biology 42 (6):e168-e185. https:\/\/doi.org\/10.1161\/atv.0000000000000153","DOI":"10.1161\/atv.0000000000000153"},{"issue":"5","key":"1128_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology (Baltimore MD). 2020;72(5):1605\u201316. https:\/\/doi.org\/10.1002\/hep.31173.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"1128_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore MD). 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"4","key":"1128_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, Eguchi Y, Geier A, Kondili LA, Kroy DC, Lazarus JV, Loomba R, Manns MP, Marchesini G, Nakajima A, Negro F, Petta S, Ratziu V, Romero-Gomez M, Sanyal A, Schattenberg JM, Tacke F, Tanaka J, Trautwein C, Wei L, Zeuzem S, Razavi H. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, united Kingdom, and united States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036.","journal-title":"J Hepatol"},{"issue":"5","key":"1128_CR8","doi-asserted-by":"publisher","first-page":"e3156","DOI":"10.1002\/dmrr.3156","volume":"35","author":"X Zhou","year":"2019","unstructured":"Zhou X, Li Y, Zhang X, Guan YY, Puentes Y, Zhang F, Speliotes EK, Ji L. Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort. Diab\/Metab Res Rev. 2019;35(5):e3156. https:\/\/doi.org\/10.1002\/dmrr.3156.","journal-title":"Diab\/Metab Res Rev"},{"issue":"6","key":"1128_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Peric\u00e0s JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V. A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390(6):497\u2013509. https:\/\/doi.org\/10.1056\/NEJMoa2309000.","journal-title":"N Engl J Med"},{"issue":"5","key":"1128_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, Kashyap S, Mechanick JI, Mouzaki M, Nadolsky K, Rinella ME, Vos MB, Younossi Z. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-Sponsored by the American association for the study of liver diseases (AASLD). Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists. 2022;28(5):528\u201362. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.010.","journal-title":"Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"issue":"17","key":"1128_CR11","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3748\/wjg.v23.i17.3150","volume":"23","author":"C Gelli","year":"2017","unstructured":"Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with the mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23(17):3150\u201362. https:\/\/doi.org\/10.3748\/wjg.v23.i17.3150.","journal-title":"World J Gastroenterol"},{"key":"1128_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3389\/fendo.2020.00607","volume":"11","author":"GM Cunha","year":"2020","unstructured":"Cunha GM, Guzman G, Correa De Mello LL, Trein B, Spina L, Bussade I, Marques Prata J, Sajoux I, Countinho W. Efficacy of a 2-Month very Low-Calorie ketogenic diet (VLCKD) compared to a standard Low-Calorie diet in reducing visceral and liver fat accumulation in patients with obesity. Front Endocrinol. 2020;11:607. https:\/\/doi.org\/10.3389\/fendo.2020.00607.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1128_CR13","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.30076","volume":"68","author":"C Properzi","year":"2018","unstructured":"Properzi C, O\u2019Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, Tibballs J, MacQuillan GC, Garas G, Adams LA. Ad libitum mediterranean and Low-Fat diets both significantly reduce hepatic steatosis: A randomized controlled trial. Hepatology (Baltimore MD). 2018;68(5):1741\u201354. https:\/\/doi.org\/10.1002\/hep.30076.","journal-title":"Hepatology (Baltimore MD)"},{"key":"1128_CR14","doi-asserted-by":"publisher","unstructured":"Drinda S, Grundler F, Neumann T, Lehmann T, Steckhan N, Michalsen A, Wilhelmi de Toledo F. Effects of periodic fasting on fatty liver Index-A prospective observational study. Nutrients. 2019;11(11). https:\/\/doi.org\/10.3390\/nu11112601.","DOI":"10.3390\/nu11112601"},{"issue":"4","key":"1128_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11901-020-00543-9","volume":"19","author":"A Thorp","year":"2020","unstructured":"Thorp A, Stine JG. Exercise as medicine: the impact of exercise training on nonalcoholic fatty liver disease. Curr Hepatol Rep. 2020;19(4):402\u201311. https:\/\/doi.org\/10.1007\/s11901-020-00543-9.","journal-title":"Curr Hepatol Rep"},{"issue":"11","key":"1128_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/MEG.0b013e32835793ac","volume":"24","author":"A de Piano","year":"2012","unstructured":"de Piano A, de Mello MT, Sanches Pde L, da Silva PL, Campos RM, Carnier J, Corgosinho F, Foschini D, Masquio DL, Tock L, Oyama LM, do Nascimento CM, Tufik S, D\u00e2maso AR. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol. 2012;24(11):1313\u201324. https:\/\/doi.org\/10.1097\/MEG.0b013e32835793ac.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1128_CR17","doi-asserted-by":"publisher","first-page":"1081096","DOI":"10.3389\/fendo.2023.1081096","volume":"14","author":"XN Chai","year":"2023","unstructured":"Chai XN, Zhou BQ, Ning N, Pan T, Xu F, He SH, Chen NN, Sun M. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis. Front Endocrinol. 2023;14:1081096. https:\/\/doi.org\/10.3389\/fendo.2023.1081096.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1128_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3920\/bm2020.0183","volume":"12","author":"H Jin","year":"2021","unstructured":"Jin H, Xu X, Pang B, Yang R, Sun H, Jiang C, Shao D, Shi J. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. Beneficial Microbes. 2021;12(6):517\u201329. https:\/\/doi.org\/10.3920\/bm2020.0183.","journal-title":"Beneficial Microbes"},{"key":"1128_CR19","doi-asserted-by":"publisher","unstructured":"Kei N, Wong VWS, Lauw S, You L, Cheung PCK. Utilization of Food-Derived \u03b2-Glucans to prevent and treat Non-Alcoholic fatty liver disease (NAFLD). Foods (Basel Switzerland). 2023;12(17). https:\/\/doi.org\/10.3390\/foods12173279.","DOI":"10.3390\/foods12173279"},{"issue":"5","key":"1128_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Reviews Endocrinol. 2019;15(5):261\u201373. https:\/\/doi.org\/10.1038\/s41574-019-0156-z.","journal-title":"Nat Reviews Endocrinol"},{"issue":"6","key":"1128_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/mcg.0000000000000116","volume":"48","author":"DR LaBrecque","year":"2014","unstructured":"LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Pe\u00f1aranda MM, Ramos JF, Sarin S, Stimac D, Thomson AB, Umar M, Krabshuis J, LeMair A. World gastroenterology organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol. 2014;48(6):467\u201373. https:\/\/doi.org\/10.1097\/mcg.0000000000000116.","journal-title":"J Clin Gastroenterol"},{"key":"1128_CR22","doi-asserted-by":"publisher","unstructured":"Warburton DE, Jamnik VK, Bredin SS, McKenzie DC, Stone J, Shephard RJ, Gledhill N. (2011) Evidence-based risk assessment and recommendations for physical activity clearance: an introduction. Applied physiology, nutrition, and metabolism\u2009=\u2009Physiologie appliquee, nutrition et metabolisme 36 Suppl 1:S1-2. https:\/\/doi.org\/10.1139\/h11-060","DOI":"10.1139\/h11-060"},{"issue":"8","key":"1128_CR23","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jamainternmed.2016.3202","volume":"176","author":"HJ Zhang","year":"2016","unstructured":"Zhang HJ, He J, Pan LL, Ma ZM, Han CK, Chen CS, Chen Z, Han HW, Chen S, Sun Q, Zhang JF, Li ZB, Yang SY, Li XJ, Li XY. Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: A randomized clinical trial. JAMA Intern Med. 2016;176(8):1074\u201382. https:\/\/doi.org\/10.1001\/jamainternmed.2016.3202.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"1128_CR24","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1136\/gut.2011.242073","volume":"60","author":"K Hallsworth","year":"2011","unstructured":"Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60(9):1278\u201383. https:\/\/doi.org\/10.1136\/gut.2011.242073.","journal-title":"Gut"},{"issue":"6","key":"1128_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, Zheng MH, Shiha G, Yilmaz Y, Gani R, Alam S, Dan YY, Kao JH, Hamid S, Cua IH, Chan WK, Payawal D, Tan SS, Tanwandee T, Adams LA, Kumar M, Omata M, George J. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hep Intl. 2020;14(6):889\u2013919. https:\/\/doi.org\/10.1007\/s12072-020-10094-2.","journal-title":"Hep Intl"},{"issue":"3","key":"1128_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3760\/cma.j.issn.1007-3418.2018.03.008","volume":"26","author":"National Workshop on Fatty Liver and Alcoholic Liver Disease C S O H, Chinese Medical Association., Fatty Liver Expert Committee C M D A","year":"2018","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease C S O H, Chinese Medical Association., Fatty Liver Expert Committee C M D A. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update[J]. Chin J Hepatol. 2018;26(3):195\u2013203. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2018.03.008.","journal-title":"Chin J Hepatol"},{"key":"1128_CR27","doi-asserted-by":"publisher","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59(6):1121\u201340. https:\/\/doi.org\/10.1007\/s00125-016-3902-y.","DOI":"10.1007\/s00125-016-3902-y"},{"issue":"1","key":"1128_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology (Baltimore MD). 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology (Baltimore MD)"},{"key":"1128_CR29","doi-asserted-by":"publisher","first-page":"987921","DOI":"10.3389\/fnut.2022.987921","volume":"9","author":"HK Varkaneh","year":"2022","unstructured":"Varkaneh HK, Poursoleiman F, Al Masri MK, Alras KA, Shayah Y, Masmoum MD, Alangari FA, Alras AA, Rinaldi G, Day AS, Hekmatdoost A, Abu-Zaid A, Kutbi E. Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review. Front Nutr. 2022;9:987921. https:\/\/doi.org\/10.3389\/fnut.2022.987921.","journal-title":"Front Nutr"},{"issue":"7","key":"1128_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Reviews Gastroenterol Hepatol. 2016;13(7):412\u201325. https:\/\/doi.org\/10.1038\/nrgastro.2016.85.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"4","key":"1128_CR31","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00394-021-02763-1","volume":"61","author":"E Llanaj","year":"2022","unstructured":"Llanaj E, Dejanovic GM, Valido E, Bano A, Gamba M, Kastrati L, Minder B, Stojic S, Voortman T, Marques-Vidal P, Stoyanov J, Metzger B, Glisic M, Kern H, Muka T. Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2022;61(4):1749\u201378. https:\/\/doi.org\/10.1007\/s00394-021-02763-1.","journal-title":"Eur J Nutr"},{"key":"1128_CR32","unstructured":"Nutraceutical Improvement of Glucose Metabolism. NAFLD and insulin resistance by Oat-fiber supplementation in type 2 diabetes Mellitus Patients (2022) https:\/\/clinicaltrials.gov\/study\/NCT05654805"},{"key":"1128_CR33","unstructured":"Effectiveness of Vitamin E Incorporated Oat Supplementation in Metabolic Syndrome. (2022) https:\/\/clinicaltrials.gov\/study\/NCT05604300"},{"issue":"10","key":"1128_CR34","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1055\/a-0668-2891","volume":"56","author":"A Schweinlin","year":"2018","unstructured":"Schweinlin A, Ulbrich S, Stau\u00df S, Teutsch M, Walle H, Basrai M, Bischoff SC. [Comparison of a commercially available, formula-based nutritional therapy enriched with Oats fiber with a non-formula isocaloric therapy to treat non-alcoholic fatty liver disease (NAFLD) - a randomized, controlled intervention trial]. Z Gastroenterol. 2018;56(10):1247\u201356. https:\/\/doi.org\/10.1055\/a-0668-2891.","journal-title":"Z Gastroenterol"},{"issue":"3","key":"1128_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745\u201350. https:\/\/doi.org\/10.1053\/gast.2002.35354.","journal-title":"Gastroenterology"},{"issue":"1","key":"1128_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiol.2019190467","volume":"294","author":"Z Guo","year":"2020","unstructured":"Guo Z, Blake GM, Li K, Liang W, Zhang W, Zhang Y, Xu L, Wang L, Brown JK, Cheng X, Pickhardt PJ. Liver fat content measurement with quantitative CT validated against MRI proton density fat fraction: A prospective study of 400 healthy volunteers. Radiology. 2020;294(1):89\u201397. https:\/\/doi.org\/10.1148\/radiol.2019190467.","journal-title":"Radiology"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-025-01128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T13:39:49Z","timestamp":1745674789000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-025-01128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1186\/s12937-025-01128-2","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol has been approved by the Ethics Committee of Beijing Pinggu Hospital (Reference No: 2019 - Capital\u2019s Funds for Health Improvement and Research 004\u2009\u2212\u200901). All participants will sign an informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}